Know Cancer

or
forgot password

Phase III Study for the Significance of Nasogastric Decompression Tube After Curative Distal Gastrectomy for Gastric Cancer Patients


Phase 3
20 Years
80 Years
Not Enrolling
Both
Gastric Cancer

Thank you

Trial Information

Phase III Study for the Significance of Nasogastric Decompression Tube After Curative Distal Gastrectomy for Gastric Cancer Patients


Nasogastric decompression tube is an intra-operative routine in most of the time to
facilitate exposure of operative field during elective distal gastrectomy, however, whether
it should be retained post-operatively is controversial. Nasogastric decompression tube
helps to drain the gastric remnant in case there is edema around the gastrojejunostomy,
ileus and delayed gastric emptying, which can theoretically relieve nausea and abdominal
distension. However, nasogastric intubation could cause patients discomfort; also it has
been shown that it would cause gastroesophageal reflux which may be associated with
pulmonary complication.


Inclusion Criteria:



- on the basis of whether distal gastrectomy was anticipated at WMUH for gastric
cancer.

Exclusion Criteria:

- patients who were diagnosed inadequacy for this study by a physician.

- patients without an informed consent.

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Quality of life

Outcome Time Frame:

seven days after operation

Safety Issue:

Yes

Principal Investigator

Mikihito Nakamori, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Wakayama Medical University

Authority:

Japan: Ministry of Health, Labor and Welfare

Study ID:

WMC-RCTGastric01

NCT ID:

NCT00738478

Start Date:

February 2006

Completion Date:

December 2008

Related Keywords:

  • Gastric Cancer
  • distal gastrectomy
  • quality of life
  • Stomach Neoplasms

Name

Location